Q213991 (Q213991): Difference between revisions
Changed an Item |
Changed an Item |
||
| Property / has country associated with person [a/object] (RDA:P50097) | Property / has country associated with person [a/object] (RDA:P50097) | ||
| Property / has country associated with person [a/object] (RDA:P50097): RDA Item Placeholder / qualifier | |||
| Property / has country associated with person [a/object] (RDA:P50097): RDA Item Placeholder / qualifier | |||
| Property / has country associated with person [a/object] (RDA:P50097): RDA Item Placeholder / qualifier | |||
Revision as of 12:12, 22 November 2025
No description defined
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | No label defined |
No description defined |
Statements
Simmons
0 references
Mark A.
0 references
Τεκμήριο: Βασική φαρμακολογία, ©2023:
σελίδα τίτλου (Mark A. Simmons· PhD· καθηγητής φαρμακολογίας, Τμήμα Φαρμακευτικών Επιστημών, Φαρμακευτική Σχολή, Πανεπιστήμιο του Maryland Eastern Shore Princess Anne, Maryland· ομότιμος καθηγητής φαρμακολογίας, Department of Integrative Medical Sciences, Northeast Ohio Medical University, Rootstown, Ohio)
0 references
LC/NACO (αρχείο καθιερωμένων επικεφαλίδων), ημερομηνία προσπέλασης 22 Μαΐου 2024
(επικεφαλίδα: Simmons, Mark A.)
0 references